There are 2789 resources available
1249P - Pharmacokinetic and dose finding study of osimertinib in patients with impaired renal function and low body weight
Presenter: Tetsunari Hase
Session: ePoster Display
1250P - Differences of immune microenvironment among NSCLC patients with various KRAS mutation types
Presenter: Kun Wang
Session: ePoster Display
1273P - Sputum supernatant as a viable liquid biopsy in advanced non-small cell lung cancer
Presenter: Chengzhi Zhou
Session: ePoster Display
1254P - Efficacy and safety of tepotinib in patients (pts) with advanced age: VISION subgroup analysis of pts with MET exon 14 (METex14) skipping NSCLC
Presenter: Marina Chiara Garassino
Session: ePoster Display
1184P - Necroptosis establishes an inflammatory tumor immune microenvironment acting as tumor suppressor in lung adenocarcinoma
Presenter: Fabian Allmendinger
Session: ePoster Display
1185P - Induction immunotherapy in resectable non-small cell lung cancer harboring driver mutations: A multi-center retrospective study
Presenter: Chao Zhang
Session: ePoster Display
1186P - Study on possible mechanisms of HPD associated with the amplification of chromosome 11q13 in NSCLC
Presenter: Jie Lei
Session: ePoster Display
1187P - A mutation characteristics analysis of SMARCA4defSMARCA2wt in lung cancer
Presenter: Jisheng Li
Session: ePoster Display
1188P - Concurrent chemoradiotherapy with cisplatin + S-1 for locally advanced non-small cell lung cancer: IPD meta-analysis
Presenter: Yuri Taniguchi
Session: ePoster Display
1189P - EGFR mutation p.747_749del enhances anlotinib sensitivity by upregulating EGR1 and DUSP6 in NSCLC cells
Presenter: yu limeng
Session: ePoster Display